Stockscreener 앱 받기
228.05
1.85%
-4.29
시간 외 거래:
228.05
전일 마감가:
$232.34
열려 있는:
$231.84
하루 거래량:
1.11M
Relative Volume:
1.47
시가총액:
$16.49B
수익:
$2.88B
순이익/손실:
$499.60M
주가수익비율:
33.84
EPS:
6.74
순현금흐름:
$321.60M
1주 성능:
+3.16%
1개월 성능:
-32.34%
6개월 성능:
-25.02%
1년 성능:
-36.43%
1일 변동 폭
$223.67
$234.31
1주일 범위
$215.67
$234.31
52주 변동 폭
$197.01
$400.88
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
WST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
228.05 | 16.49B | 2.88B | 499.60M | 321.60M | 6.74 |
|
ISRG
Intuitive Surgical Inc
|
566.98 | 202.22B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
228.45 | 65.60B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
94.14 | 46.56B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
233.10 | 34.24B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
91.65 | 18.25B | 3.90B | 392.30M | 288.10M | 1.95 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
West Pharmaceutical's Long-Term Growth Intact, but Margin Expansion Less Uncertain - Morningstar
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
Do Wall Street Analysts Like West Pharmaceutical Services Stock? - MSN
West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire
Levi & Korsinsky Investigates Possible Securities Fraud Violations by West Pharmaceutical Services, Inc. (WST) - ACCESS Newswire
Healthcare Visual Inspection Services Market Report, 2030 - Grand View Research
West Pharmaceutical Services Declares $0.21 Dividend for Q2 2025 - MSN
West Pharmaceutical Services: How GLP-1 and Biologics Are Unlocking Explosive Growth! - Smartkarma
Top 2 Health Care Stocks That May Rocket Higher This Month - Benzinga
West Pharmaceutical sets Q2 dividend at $0.21 per share By Investing.com - Investing.com Australia
Insider Decision Unfolding At West Pharmaceutical Servs: Eric Green Exercises Options, Resulting In $0 - Benzinga
Chad Winters Decides To Exercise Options At West Pharmaceutical Servs Worth $0 - Benzinga
Options Exercise Update At West Pharmaceutical Servs: Kimberly MacKay Engages, Resulting In $0 - Benzinga
Engaging In Insider Activity, Cindy Reiss-Clark At West Pharmaceutical Servs Exercises Options Worth $0 - Benzinga
West Pharmaceutical Services, Inc. Announces Second Quarter 2025 Dividend, Payable on May 7, 2025 - Marketscreener.com
West Pharmaceutical Services Maintains Quarterly Dividend at $0.21 Per Share; Payable May 7 to Shareholders of Record on April 30 - Marketscreener.com
West Announces Second-Quarter Dividend - The Malaysian Reserve
West Pharmaceutical sets Q2 dividend at $0.21 per share - Investing.com
Jefferies Adjusts West Pharmaceutical Services Price Target to $240 From $393, Maintains Buy Rating - Marketscreener.com
West Pharmaceutical Services Reports Strong Q4, Introduces 2025 Financial Guidance - MSN
WEST PHARMACEUTICAL SERVICES INC SEC 10-K Report - TradingView
Wall Street Bounces Back: Top-Performing ETFs Of Last Week - Benzinga
Why Did West Pharmaceutical Services Stock Drop Almost 40%? - Nasdaq
Why West Pharmaceutical Services (WST) Crashed Last Week? - MSN
WST Stock Declines in Pre-Market Despite Q4 Earnings Beat, Margins Down - MSN
West Pharmaceuticals Takes A Plunge, But May Still Offer Opportunities (NYSE:WST) - Seeking Alpha
West Pharma’s stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin - MSN
Reddit, GoDaddy & Trade Desk Are Among Top 11 Large-Cap Losers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio? - Benzinga
West Pharmaceutical Services, Inc. (NYSE:WST) Just Reported, And Analysts Assigned A US$306 Price Target - Yahoo Finance UK
West Pharma's 2025 Forecast Misses Estimates as Inventory Reductions Continue - Medical Dialogues
West Pharma upgraded at Deutsche Bank despite earnings led selloff - MSN
Why West Pharmaceutical Services, Inc. (WST) Went Down on Thursday - MSN
West Pharmaceutical Services, Inc. (NYSE:WST) Stock Position Raised by Van ECK Associates Corp - MarketBeat
Consolidated Planning Corp Buys 2,051 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharma stock falls as 2025 guidance disappoints - MSN
KeyCorp Has Lowered Expectations for West Pharmaceutical Services (NYSE:WST) Stock Price - MarketBeat
West Pharmaceutical Services (NYSE:WST) Sees Large Volume Increase on Better-Than-Expected Earnings - MarketBeat
West Pharmaceutical Services, Inc.'s (NYSE:WST) Popularity With Investors Under Threat As Stock Sinks 35% - Simply Wall St
West Pharmaceutical Services (NYSE:WST) Rating Increased to Buy at Deutsche Bank Aktiengesellschaft - MarketBeat
StockNews.com Upgrades West Pharmaceutical Services (NYSE:WST) to Buy - MarketBeat
West Pharma’s Stock Plummets 38% as 2025 Outlook Disappoints Investors - PUNE.NEWS
West Pharmaceutical Unveils New Nested Format for Daikyo PLASCAP RUV Closures - MSN
Dynavax Technologies Corporation Enters into an Agreement with West Pharmaceutical Services, Inc - Marketscreener.com
Sector Update: Health Care Stocks Decline Late Afternoon -February 14, 2025 at 03:59 pm EST - Marketscreener.com
West Pharmaceutical Services (NYSE:WST) Issues Earnings Results, Beats Expectations By $0.07 EPS - MarketBeat
Sector Update: Health Care Stocks Retreat Friday Afternoon -February 14, 2025 at 01:59 pm EST - Marketscreener.com
Why West Pharmaceutical Shares Are on the Rise Again - TipRanks
West Earnings: Valuation Lowered After Guidance Disappoints and Recovery Trajectory Delayed - Morningstar
West Pharmaceutical Servs's Options Frenzy: What You Need to Know - Benzinga
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.01%
0.19%
자본화:
|
볼륨(24시간):